Skip to Content

Tilray Brands Inc TLRY Stock Quote

| Rating as of


Last close prices updated as of Feb 07, 2023, 1:51 PM EST | USD | BATS BZX Real-Time Price
  • Last Close 3.19
  • Sector Healthcare
  • Industry Drug Manufacturers - Specialty & Generic
  • Investment Style Small Value
  • Day Range 3.02  –  3.20
  • Year Range 2.52  –  9.08
  • Market Cap 1.8710 Bil
  • Volume / Avg 12.4 Mil /  20.9 Mil
  • Price / Sales 2.90
  • Price / Book 0.44
  • Forward Div Yield
  • Trailing Div Yield

Morningstar‘s Stock Analysis TLRY

Currency in
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price


5-Star Price


Economic Moat


Capital Allocation


Slashing Tilray’s FVE as Canadian Market Growing More Slowly Than We Expected in Fiscal Q2

Analyst Note

| Kristoffer Inton |

We’ve lowered our fair value estimate for Tilray to $8 and CAD 10, from $12 and CAD 16, respectively, following slower growth in the Canadian market than we expected during its fiscal second quarter. Net revenue growth declined 6% sequentially and 7% year on year primarily from cannabis. Even excluding currency headwinds, net revenue still declined 5% sequentially and grew just 2% year on year. Also, fierce competition in the crowded Canadian market continues to weigh on prices, also contributing to top-line headwinds. Despite cost initiatives, adjusted EBITDA decreased 13% sequentially and 15% year on year to about $11.7 million. Despite our cut, no-moat Tilray’s shares remain undervalued and well-positioned in the challenging Canadian market.

Unlock Our Full Analysis With Morningstar Investor

Key Statistics TLRY

Company Profile TLRY

Business Description

Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. U.S. exposure consists of CBD products through Manitoba Harvest and beer through SweetWater.

265 Talbot Street West
Leamington, ON, N8H 5L4, CAN
Industry Drug Manufacturers - Specialty & Generic
Employees 1,750

FAQs for Tilray Brands Inc Stock

No. TLRY does not currently have a forward dividend yield.
Dividend yield allows investors, particularly those interested in dividend-paying stocks, to compare the relationship between a stock’s price and how it rewards stockholders through dividends. The formula for calculating dividend yield is to divide the annual dividend paid per share by the stock price.

Learn more about dividend yield.

TLRY’s market cap is 1.87 Bil.
Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares. It’s often used to measure a company’s size. In the Morningstar Style Box, large-cap names account for the largest 70% of U.S. stocks, mid-cap names account for the largest 70–90%, and small-cap names are the remaining 10% of companies.

Learn more about market capitalization.

TLRY’s stock style is Small Value.
Style is an investment factor that has a meaningful impact on investment risk and returns. Style is calculated by combining value and growth scores, which are first individually calculated.

High-growth stocks tend to represent the technology, healthcare, and communications sectors. They rarely distribute dividends to shareholders, opting for reinvestment in their businesses. More value-oriented stocks tend to represent financial services, utilities, and energy stocks. These are established companies that reliably pay dividends.

Learn more about style.

TLRY’s beta can be found in Trading Information at the top of this page.
A stock’s beta measures how closely tied its price movements have been to the performance of the overall market.

Compare TLRY’s historical performance against its industry peers and the overall market.